PRESS RELEASE: Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference. Link: escortbayan.ru AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of Stay up-to-date on Akebia Therapeutics, Inc. Common Stock (AKBA) news with the latest updates, breaking headlines, news articles, and more from around the. FibroGen Inc. $ FGEN % ; In the news. Yahoo Finance. 1 week ago. Here's Why You Should Consider Buying Akebia (AKBA) Stock ; Income Statement. The latest Akebia Therapeutics stock prices, stock quotes, news, and AKBA history to help you invest and trade smarter.
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. CAMBRIDGE, Mass., May 2, /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first. Breaking Akebia shares jump on expanded anemia drug deal with Otsuka. Akebia Therapeutics Inc. shares jumped in the extended session Tuesday after the biotech. escortbayan.ru cut shares of Akebia Therapeutics from a "buy" rating to a "hold" rating in a research note on Thursday. Akebia Therapeutics stock price. See the latest Akebia Therapeutics Inc stock price (AKBA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney. Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue Estimates. Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of % and %. Ratings · Akebia Therapeutics Analyst Ratings · Express News | Akebia Therapeutics, Inc.: H.c. Wainwright Raises Target Price to $ From $6 · Akebia. Akebia Therapeutics, Inc. today announced the pricing of its initial public offering of 5,, shares of common stock at an initial public offering price of. AKBA Akebia Therapeutics Inc. 19, $ $ (%). Today. Watchers, 19, Wk Low, $ Wk High, $ Market Cap, $M. Akebia Therapeutics shares are trading lower. Benzinga Newsdesk - May 9, , AM Akebia Therapeutics Q1 GAAP EPS $().
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is a fully integrated biopharmaceutical company headquartered in Cambridge, Massachusetts. Press Releases ; August 1, Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule (c)(4) ; July 29, Akebia Therapeutics to. Today's High; $ ; Today's Low; $ ; 52 Week High; $ ; 52 Week Low; $ Based on short-term price targets offered by three analysts, the average price target for Akebia Therapeutics comes to $ The forecasts range from a low of. Discover real-time Akebia Therapeutics, Inc. Common Stock (AKBA) stock prices, quotes, historical data, news, and Insights for informed trading and. Akebia Therapeutics, Inc NASDAQ: AKBA is a biopharmaceutical company is focused on producing medicines for people living with kidney disease. Get Akebia Therapeutics Inc (AKBA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. In the current month, AKBA has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AKBA average Analyst price target in the past 3 months is $ Akebia Therapeutics on Thursday said it regained full U.S. rights to its chronic kidney disease anemia drug Vafseo, which the biotech has priced at around.
Akebia Therapeutics Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Neutral. AKBA Sentiment. Content From Our Affiliates · Akebia price target raised to $ from $6 at H.C. · Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax. stocks are traded under the ticker AKBA. Is Akebia Therapeutics, Inc. stock price growing? Akebia is holding the Special Meeting to seek stockholder approval to, among other things, effect a reverse stock split of Akebia's common stock, which Akebia. View Akebia Therapeutics (AKBA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.
News for Akebia Therapeutics Inc ; 5d. Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax Labs (GOVX), Akebia Therapeutics (AKBA) and.
Recession Risk Looms: Fed Cuts and S\u0026P 500 Impact as Labor Market Weakens - Peter Berezin
Zantac And Ranitidine Lawsuit | How To Earn Free Money By Playing Games